These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Simultaneous tracing of 76Se-selenite and 77Se-selenomethionine by absolute labeling and speciation. Suzuki KT; Somekawa L; Kurasaki K; Suzuki N Toxicol Appl Pharmacol; 2006 Nov; 217(1):43-50. PubMed ID: 16956638 [TBL] [Abstract][Full Text] [Related]
46. Growth-hormone and somatostatin effects on [75Se]selenomethionine uptake by the pancreas. Atkins HL; Som P J Nucl Med; 1979 Jun; 20(6):543-6. PubMed ID: 536826 [TBL] [Abstract][Full Text] [Related]
47. The distribution of 75Se-adenosyl selenomethionine in the rat with observations on its potential as a prostate scanning agent. Eakins MN Eur J Nucl Med; 1979 Apr; 4(2):101-3. PubMed ID: 499233 [TBL] [Abstract][Full Text] [Related]
48. Parathyroid scanning in the human with selenomethionine-75Se. McGeown MG; Bell TK; Soyannwo MA; Fenton SS; Oreopoulos D Br J Radiol; 1968 Apr; 41(484):300-6. PubMed ID: 5647986 [No Abstract] [Full Text] [Related]
49. Selenomethionine selenium-75 scintiscanning of the pancreas. Chen CC; Wang KC Taiwan Yi Xue Hui Za Zhi; 1969 Jul; 68(7):341-9. PubMed ID: 5259192 [No Abstract] [Full Text] [Related]
50. Brain uptake of selenomethionine Se 75. I. Effects of elevated blood levels of methionine and phenylalanine. Oldendorf WH; Sisson WB; Mehta AC; Treciokas L Arch Neurol; 1971 May; 24(5):423-30. PubMed ID: 5554866 [No Abstract] [Full Text] [Related]
51. [Method of analysis of regional dynamics of the pancreas with 75Se-selenomethionine]. Nakanishi F; Kasuga T; Kobayashi T; Miyabayashi H; Yano K Kaku Igaku; 1977 Apr; 14(2):223-32. PubMed ID: 559835 [No Abstract] [Full Text] [Related]
52. [Isotopic exploration of the pancreas with selenomethionine. Apropos of 60 cases]. Swyngedauw J; Tacquet A; Foissac-Gegoux P; Huart M Rev Med Liege; 1968 Oct; ():Suppl 1:95+. PubMed ID: 5712344 [No Abstract] [Full Text] [Related]
53. Metabolism of 76Se-methylselenocysteine compared with that of 77Se-selenomethionine and 82Se-selenite. Suzuki KT; Doi C; Suzuki N Toxicol Appl Pharmacol; 2006 Dec; 217(2):185-95. PubMed ID: 17056079 [TBL] [Abstract][Full Text] [Related]
54. Bioavailability of selenium to residents in a low-selenium area of China. Luo XM; Wei HJ; Yang CL; Xing J; Liu X; Qiao CH; Feng YM; Liu J; Liu YX; Wu Q Am J Clin Nutr; 1985 Sep; 42(3):439-48. PubMed ID: 4036848 [TBL] [Abstract][Full Text] [Related]
55. Radioisotopic "subtraction" scanning for pancreatic lesions. Eaton SB; Potsaid MS; Lo HH; Beaulieu E Radiology; 1967 Dec; 89(6):1033-9. PubMed ID: 6059622 [No Abstract] [Full Text] [Related]
57. Experimental suppression of hepatic uptake of 75Se-selenomethionine. Cho KJ; Doust BD J Nucl Med; 1974 Dec; 15(12):1171-3. PubMed ID: 4427145 [No Abstract] [Full Text] [Related]
58. Primary hyperparathyroidism and selenomethionine-75Se scanning: recent experiences in a Head and Neck Unit. Newton NC; Sumich MG; Jenkinson IS Med J Aust; 1968 Aug; 2(5):205-10. PubMed ID: 5676201 [No Abstract] [Full Text] [Related]
59. Seleno methionine-75 as a scanning agent for neuroblastoma. Covington EE; D'Angio GJ; Helson L; Romano RW Clin Bull; 1974; 4(4):147-50. PubMed ID: 4376978 [No Abstract] [Full Text] [Related]